ESMO 2022: Updates in Skin Cancer

On this episode, we’re highlighting speakers who presented data in skin cancer during the ESMO Congress 2022, including findings on tumor-infiltrating lymphocyte therapy in advanced melanoma, cemiplimab in cutaneous squamous cell carcinoma, and the association of circulating tumor DNA and disease recurrence in patients with later-stage melanoma.

---